Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Feb 28, 2012
0
0
Older women who have lost more than two inches in height face an increased risk of breaking bones and dying, according to a new study published in the January issue of the Journal of Bone and Mineral Research and funded by ...
Jan 10, 2012
0
0
Social contact and regular exercise are key to aging well and living a longer life, according to newly presented research.
Feb 17, 2014
0
0
Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an ...
Dec 13, 2011
0
0
For patients with ovarian cancer and their physicians, resistance to chemotherapy is a serious concern. However, researchers at Moffitt Cancer Center have identified a molecular pathway that may play a key role in the evolution ...
Sep 15, 2011
0
0
(HealthDay)—A majority of Americans (52 percent) now favor legalizing marijuana, and 72 percent feel that the government efforts to enforce marijuana laws are not worth their cost, according to research published by the ...
Apr 9, 2013
0
0
KRAS is one of the most challenging targets in cancer. Despite its discovery more than 60 years, researchers still struggle to inhibit its mutated form—earning its reputation as "undruggable." Yet, the hunt for an Achilles' ...
May 14, 2019
0
14
Smartphones have become a constant companion for many of us. In a recent study by the Pew Research Center, nearly 50 percent of adults reported they "couldn't live without" their phones.
Feb 11, 2019
0
18
As the idea of growing tiny human organs in lab dishes has moved in recent years from futuristic science fiction to actual bioscientific reality, the usefulness of organoids as a research tool for studying the digestive system ...
Jul 28, 2022
0
34
(HealthDay)—Patients diagnosed with type 2 diabetes have a greater prevalence of cancer with longer diabetes duration and with insulin use, according to a study published online Jan. 8 in Diabetes Care.
Jan 24, 2013
0
0
